jcp Videos

Videos

Videos

AI in Cancer Care: Separating Fact from Fiction

07/17/2023

Featuring Ira Klein, MD

CBEx Advisory Board Member Ira Klein, MD, VP of Medical Affairs for Tempus Labs, provides an inside look into featured session "AI in Cancer Care: Separating Fact from Fiction."

CBEx Advisory Board Member Ira...

07/17/2023

Cancer Care Business Exchange

Videos

Comparison of Diversity Across Real-World Evidence, Randomized Clinical Trial, and SEER Data in Patients With Metastatic Breast Cancer

07/12/2023

Featuring Danielle Gentile, PhD

Featuring Danielle Gentile, PhD ...

Danielle Gentile, PhD, a senior scientist on Cardinal Health’s real-world evidence and insights team, discusses her research comparing diversity in real-world evidence, RCTs, and SEER data in patients with metastatic breast cancer.

Danielle Gentile, PhD, a senior...

07/12/2023

Journal of Clinical Pathways

Videos

Clinical Value of Timely Targeted Therapy for Patients With Advanced Non–Small Cell Lung Cancer

07/12/2023

Featuring Thomas Stricker, MD

Thomas Stricker, MD, PhD, speaks with the Journal of Clinical Pathways about his research on the clinical impact of the timing of first line targeted therapy in aNSCLC patients with actionable driver oncogenes.

Thomas Stricker, MD, PhD, speaks...

07/12/2023

Journal of Clinical Pathways

Videos

Real-World Response Endpoints in Patients With mNSCLC Treated With Chemotherapy Across Real-World Datasets

07/03/2023

Featuring Janet Espirito, PharmD

Featuring Janet Espirito, PharmD ...

Janet L. Espirito, PharmD, Senior Medical Director for Ontada, speaks with the Journal of Clinical Pathways about the significance of her research on real-world response endpoints in patients with mNSCLC treated with chemotherapy across...

Janet L. Espirito, PharmD,...

07/03/2023

Journal of Clinical Pathways

Videos

Perspective on Lessons Learned from Academic Practices Participating in OCM

06/30/2023

Featuring Theresa Dreyer, MPH

Theresa Dreyer, MPH, value-based care team lead for the Association of American Medical Colleges (AAMC), shares further insights from her ASCO 2023 presentation and discusses the benefits and challenges for academic practices participating in...

Theresa Dreyer, MPH, value-based...

06/30/2023

Journal of Clinical Pathways

Videos

Health Care Access and Affordability for Adult Immigrant Cancer Survivors

06/26/2023

Featuring Patricia Santos, MD

Patricia Santos, MD, Memorial Sloan Kettering Cancer Center, spoke with the Journal of Clinical Pathways at the ASCO 2023 Annual Meeting about her research on the coverage and affordability of health care access for adult immigrant cancer...

Patricia Santos, MD, Memorial...

06/26/2023

Journal of Clinical Pathways

Videos

How Will the Chemotherapy Shortage Affect Health Policy in the US?

06/22/2023

Alyssa Schatz, MSW, Senior Director of Policy and Advocacy, NCCN, speaks with the Journal of Clinical Pathways about the current chemotherapy shortage affecting cancer treatment in the US.

Alyssa Schatz, MSW, Senior...

06/22/2023

Cancer Care Business Exchange

Videos

A Real-World Analysis of Factors Leading to Racial Disparities in the Overall Survival of Patients with CLL

06/22/2023

Featuring Adam Kittai, MD

Adam Kittai, MD, The Ohio State University Comprehensive Cancer Center, discusses his study on the causes of racial disparities in the overall survival of patients with chronic lymphocytic leukemia.

Adam Kittai, MD, The Ohio State...

06/22/2023

Journal of Clinical Pathways

Videos

The Impact of Social Determinants of Health on Use of Germline Genetic Testing for Triple-Negative Breast Cancer

06/20/2023

Featuring Barb Kunz

Barb Kunz, the US Oncology Network, discusses her study on the impact of social determinants of health on use of germline genetic testing for triple-negative breast cancer in the community oncology setting.

Barb Kunz, the US Oncology...

06/20/2023

Journal of Clinical Pathways

ENGAGING EXPERTS

Antitumor Activity of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer

06/19/2023

Featuring Rana McKay, MD

Dr Rana McKay, a genitourinary medical oncologist at the University of California San Diego, discusses the results of EV-103 cohort K, which assessed the efficacy of enfortumab vedotin monotherapy or in combination with pembrolizumab in...

Dr Rana McKay, a genitourinary...

06/19/2023

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Videos

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products